EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment

Bruce L Zuraw, Konrad Bork, Laurence Bouillet, Sandra C Christiansen, Henriette Farkas, Anastasios E Germenis, Anete S Grumach, Allen Kaplan, Alberto López-Lera, Markus Magerl, Marc A Riedl, Adil Adatia und 23 weitere

Clinical Reviews in Allergy & Immunology · 07.03.2025 · 68 (1)

DOI: 10.1007/s12016-025-09027-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Reviews in Allergy & Immunology, online erschienen am 07.03.2025. Verfasst von Bruce L Zuraw und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Allergy & Immunology, University of California San Diego, 9500 Gilman Drive, Mail Code 0732, La Jolla, CA, 92093,…. Hauptthemen laut MEDLINE: Angioedemas, Hereditary, Complement C1 Inhibitor Protein. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hereditary angioedema (HAE) has been recognized for almost 150 years. The newest form of HAE, where C1 inhibitor levels are normal (HAE-nC1INH), was first described in 2000. Over the last two decades, new types of apparent non-mast cell–mediated angioedema with normal quantity and activity of C1INH have been described, in some cases with proven genetic pathogenic variants that co-segregate with angioedema expression within families. Like HAE due to C1INH deficiency, HAE-nC1INH patients are at risk of serious morbidity and mortality. Therefore, proactive management and treatment of HAE-nC1INH patients after an expert physician diagnosis is critically important. The underlying pathophysiology responsible for the angioedema has also been clarified in some of the HAE-nC1INH types. While several clinical guidelines and practice parameters including HAE-nC1INH have been published, we have made substantial progress in our understanding encompassing diagnostic criteria, pathophysiology, and treatment outcomes. HAE International (HAEi) and the US HAE Association (HAEA) convened a symposium of global HAE-nC1INH experts to synthesize our current knowledge in the area. Given the paucity of high-level evidence in HAE-nC1INH, all recommendations are based on expert opinion. This review and expert opinion on the best practice approach to diagnosing and treating HAE-nC1INH will support physicians to better manage patients with HAE-nC1INH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioedemas, HereditaryComplement C1 Inhibitor ProteinHumansDisease Management

Stichwörter der Autor:innen

BradykininDiagnosisHAEHAE-C1INHHAE-nC1INHPathophysiologyTreatment

Substanzen

Complement C1 Inhibitor Protein

Autor:innen und Institutionen

  • Department of Medicine, Division of Allergy & Immunology, University of California San Diego, 9500 Gilman Drive, Mail Code 0732, La Jolla, CA, 92093, USA. bzuraw@health.ucsd.edu.
  • Medicine Service, San Diego VA Healthcare, San Diego, USA. bzuraw@health.ucsd.edu.
  • Department of Dermatology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • University Grenoble Alpes, T-RAIG Unit, CNRS, UMR 5525, TIMC, Grenoble, France.
  • French National Reference Center for Angioedema (CREAK), Internal Medicine Department, Grenoble University Hospital, Grenoble, France.
  • Department of Medicine, Division of Allergy & Immunology, University of California San Diego, 9500 Gilman Drive, Mail Code 0732, La Jolla, CA, 92093, USA.

Zitieren

APA

Zuraw, B. L., Bork, K., Bouillet, L., Christiansen, S. C., Farkas, H., Germenis, A. E., Grumach, A. S., Kaplan, A., López-Lera, A., Magerl, M., Riedl, M. A., Adatia, A., Banerji, A., Betschel, S., Boccon-Gibod, I., Bova, M., Boysen, H. B., Caballero, T., Cancian, M., …, & Maurer, M. (2025). Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment. Clinical Reviews in Allergy & Immunology, 68(1). https://doi.org/10.1007/s12016-025-09027-4

Vancouver

Zuraw BL, Bork K, Bouillet L, Christiansen SC, Farkas H, Germenis AE, et al. Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment. Clinical Reviews in Allergy & Immunology. 2025;68(1). doi:10.1007/s12016-025-09027-4

BibTeX
@article{Zuraw2025,
  author = {Zuraw, Bruce L and Bork, Konrad and Bouillet, Laurence and Christiansen, Sandra C and Farkas, Henriette and Germenis, Anastasios E and Grumach, Anete S and Kaplan, Allen and López-Lera, Alberto and Magerl, Markus and Riedl, Marc A and Adatia, Adil and Banerji, Aleena and Betschel, Stephen and Boccon-Gibod, Isabelle and Bova, Maria and Boysen, Henrik Balle and Caballero, Teresa and Cancian, Mauro and Castaldo, Anthony J and Cohn, Danny M and Corcoran, Deborah and Drouet, Christian and Fukunaga, Atsushi and Hide, Michihiro and Katelaris, Constance H and Li, Philip H and Longhurst, Hilary and Peter, Jonny and Psarros, Fotis and Reshef, Avner and Ritchie, Bruce and Selva, Christine N and Zanichelli, Andrea and Maurer, Marcus},
  title = {Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment},
  journal = {Clinical Reviews in Allergy & Immunology},
  year = {2025},
  volume = {68},
  number = {1},
  doi = {10.1007/s12016-025-09027-4}
}
Kostenlos starten →